Sorafenib tosylate in advanced kidney cancer: past, present and futureCamillo Porta, Elisa Ferraris, Chiara Paglino et al.|Anti-Cancer Drugs|2009Cited by 23
252 RETROSPECTIVE ANALYSIS OF THE SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)Camillo Porta, Emilio Bajetta, Elisa Ferraris et al.|European Urology Supplements|2009Cited by 23
Use of Sorafenib in Two Metastatic Renal Cell Cancer Patients with End-Stage Renal Impairment Undergoing Replacement HemodialysisElisa Ferraris, Camillo Porta, Pamela Di Cesare et al.|Tumori Journal|2009Cited by 17
Lingual Metastasis from Renal Cell Carcinoma: A Case Report and Literature ReviewCarlo Ganini, Camillo Porta, Angioletta Lasagna et al.|Rare Tumors|2012Cited by 15
Lingual metastasis from renal cell carcinoma: a case report and literature reviewCarlo Ganini, Camillo Porta, Angioletta Lasagna et al.|Rare Tumors|2012Cited by 14